고려제약

014570KOSDAQ

57.5 / 100

Reference Date: 2026-09-08

Financial Score28.0 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Slightly up 1.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Korea Pharmaceutical Co., Ltd. is a leading South Korean manufacturer of over-the-counter and specialty pharmaceuticals, renowned for its cold remedy 'Haben' and treatments for CNS diseases such as epilepsy and Parkinson's. The company's flagship products include CNS medications, which are sold through pharmacies, hospitals, and international exports, while also focusing on R&D for new drugs and health functional foods.

Number of Employees

238people

Average Salary

55.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

5.91Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR

0.46Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

8.08Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

3.56Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼12.3% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼36.8% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 2.0% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (23%)

Current 3,500Won52-week high 4,64552-week low 3,155

1-month return3.0Point

1m 1.16% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14